In This Article:
As global markets experience heightened volatility due to escalating Middle East tensions and economic uncertainties, the German market has not been immune, with the DAX index recently experiencing a notable decline. In this environment of caution and shifting investor sentiment, identifying stocks with solid fundamentals becomes crucial for navigating potential opportunities.
Top 10 Undiscovered Gems With Strong Fundamentals In Germany
| Name | Debt To Equity | Revenue Growth | Earnings Growth | Health Rating |
|---|---|---|---|---|
| Mineralbrunnen Überkingen-Teinach GmbH KGaA | 19.91% | 0.96% | -5.02% | ★★★★★★ |
| Westag | NA | -1.56% | -21.68% | ★★★★★★ |
| FRoSTA | 8.18% | 4.36% | 16.00% | ★★★★★★ |
| Mühlbauer Holding | NA | 10.49% | -12.73% | ★★★★★★ |
| Paul Hartmann | 26.29% | 1.12% | -17.65% | ★★★★★☆ |
| EnviTec Biogas | 48.48% | 20.85% | 46.34% | ★★★★★☆ |
| HOMAG Group | NA | -31.14% | 23.43% | ★★★★★☆ |
| Baader Bank | 91.28% | 12.42% | -8.00% | ★★★★★☆ |
| DFV Deutsche Familienversicherung | NA | 19.63% | 62.92% | ★★★★★☆ |
| Wilson | 64.79% | 30.09% | 68.29% | ★★★★☆☆ |
Let's uncover some gems from our specialized screener.
Paul Hartmann
Simply Wall St Value Rating: ★★★★★☆
Overview: Paul Hartmann AG is a company that manufactures and sells medical and care products across Germany, the rest of Europe, the Middle East, Africa, Asia-Pacific, and the Americas with a market cap of approximately €721 million.
Operations: Paul Hartmann AG generates revenue primarily from its Incontinence Management segment (€769.70 million), followed by Wound Care (€597.39 million) and Infection Management (€516.66 million). The Complementary divisions contribute €499.70 million to the overall revenue stream.
Paul Hartmann, a notable player in the medical equipment sector, has seen its earnings soar by 156% over the past year, outpacing industry growth of 16%. Despite an increase in debt to equity from 12% to 26.3% over five years, its interest payments are comfortably covered with EBIT at 6.2x coverage. The company is trading significantly below estimated fair value and reported net income of €42.8 million for the first half of 2024, up from €11.69 million last year.
-
Navigate through the intricacies of Paul Hartmann with our comprehensive health report here.
-
Evaluate Paul Hartmann's historical performance by accessing our past performance report.
MLP
Simply Wall St Value Rating: ★★★★★★
Overview: MLP SE, with a market cap of €654.69 million, operates in Germany offering financial services to private, corporate, and institutional clients through its subsidiaries.
Operations: MLP SE generates revenue through several segments, with Financial Consulting contributing €429.61 million and FERI adding €231.23 million. Banking services account for €206.97 million, while DOMCURA brings in €129.26 million. The company also reports a negative consolidation impact of -€86.32 million on its overall financials.